40 results
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
be available, including continuing to pursue its strategy as a standalone company or pursuing potential strategic or financing transactions with third parties … to the Company’s business, operations, assets, financial condition, earnings, ownership structure, management, strategy, competitive position, current, historical
SC14D9C
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
Written communication relating to third party tender offer
4:02pm
by terminology such as “believe,” “may,” “will,” “should”, “predict”, “goal”, “strategy”, “potentially,” “estimate,” “continue,” “anticipate,” “intend … affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial
8-K
2l3m8uo78nz 4ip9
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
zgymiewx6d
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-99.1
hnh1 ogr0ap
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-99.2
6c4nc5f
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
8-K
EX-99.1
lek8 148t
30 Nov 22
Other Events
4:00pm
424B3
slji5
6 May 21
Prospectus supplement
12:00am